GMSC provides end-to-end supply chain services for medical products. Credit: Panchenko Vladimir/Shutterstock.

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS).

The shares were purchased from GlobalOne Healthcare Holding (GHH), the Yas Holding’s healthcare division, which will retain a 20% stake in each of the two firms.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

GMSC, founded in 2015, is a specialist in end-to-end supply chain services for medical products.

The company’s services include demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

Catering to over 200 medical facilities in the UAE, GMSC is a key player in providing hospitals, clinics, and healthcare providers with supply chain solutions.

IDS, which boasts a portfolio of over 1,000 products from more than 40 suppliers, stands as a pharmaceutical and consumer healthcare products distributor in the UAE.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

IDS’s distribution network spans hospitals, pharmacies, and supermarkets.

As reported by Gulf Business, Mubadala UAE Investments Platform UAE Clusters executive director Ismail Ali Abdulla said: “By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE.

“This acquisition will enable Mubadala to encompass the entire value chain — from logistics and distribution to specialised manufacturing — strengthening the UAE’s position in the global healthcare market.”

The acquisition fits into Mubadala’s strategy to consolidate and grow its investments in the life sciences industry.

Yas Holding group CEO Low Ping said: “This transaction continues Mubadala’s strategic expansion, following the recent acquisition of a 100% stake in four pharma assets from GHH by KELIX Bio, Mubadala’s specialty pharmaceutical business.

“These moves are aligned with our vision of strengthening the UAE’s healthcare and pharmaceutical sectors as part of our wider commitment to economic diversification and enhancing healthcare outcomes.”